Fourpath Capital Management LLC Has $722,000 Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Fourpath Capital Management LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 10.8% in the 1st quarter, Holdings Channel reports. The firm owned 1,379 shares of the healthcare conglomerate’s stock after selling 167 shares during the quarter. Fourpath Capital Management LLC’s holdings in UnitedHealth Group were worth $722,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Geode Capital Management LLC lifted its position in UnitedHealth Group by 1.6% in the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate’s stock worth $10,068,869,000 after purchasing an additional 319,515 shares during the period. Capital International Investors raised its stake in UnitedHealth Group by 6.2% during the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate’s stock worth $7,899,905,000 after acquiring an additional 906,365 shares in the last quarter. Norges Bank acquired a new position in UnitedHealth Group during the fourth quarter worth $6,375,744,000. Northern Trust Corp raised its stake in UnitedHealth Group by 12.5% during the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate’s stock worth $4,807,527,000 after acquiring an additional 1,058,488 shares in the last quarter. Finally, Franklin Resources Inc. raised its stake in UnitedHealth Group by 10.7% during the fourth quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate’s stock worth $4,514,178,000 after acquiring an additional 861,854 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

Shares of UNH opened at $303.08 on Tuesday. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market cap of $274.94 billion, a P/E ratio of 19.55, a price-to-earnings-growth ratio of 1.37 and a beta of 0.44. The stock’s 50-day moving average price is $404.62 and its two-hundred day moving average price is $480.59.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter last year, the firm earned $6.91 EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.92%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s dividend payout ratio is 37.02%.

Insiders Place Their Bets

In related news, CFO John F. Rex acquired 17,175 shares of UnitedHealth Group stock in a transaction on Friday, May 16th. The stock was purchased at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the transaction, the chief financial officer now directly owns 203,796 shares in the company, valued at $59,329,091.52. This trade represents a 9.20% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director John H. Noseworthy acquired 300 shares of UnitedHealth Group stock in a transaction on Wednesday, May 14th. The shares were bought at an average cost of $312.16 per share, with a total value of $93,648.00. Following the completion of the transaction, the director now owns 6,063 shares of the company’s stock, valued at approximately $1,892,626.08. This trade represents a 5.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased 109,408 shares of company stock valued at $31,607,768 in the last 90 days. 0.33% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

UNH has been the subject of several recent analyst reports. HSBC reiterated a “reduce” rating and set a $270.00 price objective (down from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Piper Sandler dropped their price objective on UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating for the company in a research note on Tuesday, June 3rd. Truist Financial restated a “buy” rating and issued a $360.00 target price (down from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Morgan Stanley lowered their target price on UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating for the company in a research note on Wednesday, May 14th. Finally, Royal Bank of Canada lowered their target price on UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating for the company in a research note on Friday, May 16th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and seventeen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $428.43.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.